A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation-Reference-Cited by-同舟云学术

A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylation

Published:2020-06-11 Issue:5 Volume:40 Page:1973-2018
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med Res Rev

Author:

Liu Aimei¹,Wu Qinghua²³,Peng Dapeng¹,Ares Irma⁴,Anadón Arturo⁴^ORCID,Lopez‐Torres Bernardo⁴,Martínez‐Larrañaga María‐Rosa⁴,Wang Xu¹⁴,Martínez María‐Aránzazu⁴

Affiliation:

1. National Reference Laboratory of Veterinary Drug Residues and MAO Key Laboratory for Detection of Veterinary Drug Residues, Huazhong Agricultural University (HZAU)Wuhan China

2. College of Life Science, Yangtze UniversityJingzhou China

3. Department of Chemistry, Faculty of ScienceUniversity of Hradec KraloveHradec Kralove Czech Republic

4. Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Research Institute Hospital 12 de Octubre (i+12)Universidad Complutense de Madrid (UCM)Madrid Spain

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities of China

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21696

Reference197 articles.

1. From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world